Literature DB >> 20204391

Non-organic hearing loss: new and confirmed findings.

Alexandra Holenweg1, Martin Kompis.   

Abstract

Although non-organic hearing losses are relatively rare, it is important to identify suspicious findings early to be able to administer specific tests, such as objective measurements and specific counseling. In this retrospective study, we searched for findings that were specific ti or typical for non-organic hearing losses. Patient records from a 6 year period (2003-2008) from the University ENT Department of Bern, Switzerland, were reviewed. In this period, 40 subjects were diagnosed with a non-organic hearing loss (22 children, ages 7-16, mean 10.6 years; 18 adults, ages 19-57, mean 39.7 years; 25 females and 15 males). Pure tone audiograms in children and adults showed predominantly sensorineural and frequency-independent hearing losses, mostly in the range of 40-60 dB. In all cases, objective measurements (otoacoustic emissions and/or auditory-evoked potentials) indicated normal or substantially better hearing thresholds than those found in pure tone audiometry. In nine subjects (22.5%; 2 children, 7 adults), hearing aids had been fitted before the first presentation at our center. Six children (27%) had a history of middle ear problems with a transient hearing loss and 11 (50%) knew a person with a hearing loss. Two new and hitherto unreported findings emerged from the analysis: it was observed that a small air-bone gap of 5-20 dB was typical for non-organic hearing losses and that speech audiometry might show considerably poorer results than expected from pure tone audiometry.

Entities:  

Mesh:

Year:  2010        PMID: 20204391     DOI: 10.1007/s00405-010-1218-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  15 in total

1.  Detection of pseudohypacusis: a prospective, randomized study of the use of otoacoustic emissions.

Authors:  Dimitrios G Balatsouras; Antonis Kaberos; Stavros Korres; Dimitrios Kandiloros; Eleftherios Ferekidis; Constantinos Economou
Journal:  Ear Hear       Date:  2003-12       Impact factor: 3.570

2.  [Simulation of deafness in expertise affairs].

Authors:  K Jahnke; D Solzbacher
Journal:  Laryngorhinootologie       Date:  2005-07       Impact factor: 1.057

Review 3.  Nonorganic hearing loss.

Authors:  James Lin; Hinrich Staecker
Journal:  Semin Neurol       Date:  2006-07       Impact factor: 3.420

4.  Examination of bone-conducted transmission from sound field excitation measured by thresholds, ear-canal sound pressure, and skull vibrations.

Authors:  Sabine Reinfeldt; Stefan Stenfelt; Tobias Good; Bo Håkansson
Journal:  J Acoust Soc Am       Date:  2007-03       Impact factor: 1.840

5.  Current evaluation of pseudohypacusis: strategies and classification.

Authors:  W W Qiu; S S Yin; F J Stucker; L W Welsh
Journal:  Ann Otol Rhinol Laryngol       Date:  1998-08       Impact factor: 1.547

6.  Childhood pseudohypacusis.

Authors:  J P Pracy; R M Walsh; G A Mepham; D A Bowdler
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1996-10       Impact factor: 1.675

7.  Psychological aspects of psychogenic deafness in children.

Authors:  M Yamamoto; J Kanzaki; K Ogawa; K Asano
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1991-04       Impact factor: 1.675

8.  [Psychogenic hearing disorders in childhood and adolescence].

Authors:  P G Zorowka
Journal:  HNO       Date:  1992-10       Impact factor: 1.284

9.  [Diagnosis of psychogenic hearing disorders in childhood].

Authors:  C Kothe; S Fleischer; A Breitfuss; M Hess
Journal:  HNO       Date:  2003-06-03       Impact factor: 1.284

10.  Childhood pseudohypacusis in patients with high risk for actual hearing loss.

Authors:  D Radkowski; S Cleveland; E M Friedman
Journal:  Laryngoscope       Date:  1998-10       Impact factor: 3.325

View more
  1 in total

Review 1.  [Nonorganic (functional) hearing loss in children].

Authors:  C-M Schmidt; A Am Zehnhoff-Dinnesen; D Deuster
Journal:  HNO       Date:  2013-02       Impact factor: 1.284

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.